Pure Global

"Leica" Surgipath Cell-freezing apparatus and reagents for in vitro diagnostic use (Non-Sterile) - Taiwan Registration d0b7755a95c6a0315121671503c0ce09

Access comprehensive regulatory information for "Leica" Surgipath Cell-freezing apparatus and reagents for in vitro diagnostic use (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number d0b7755a95c6a0315121671503c0ce09 and manufactured by LEICA BIOSYSTEMS RICHMOND INC.. The authorized representative in Taiwan is BOND BIOTECH, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
d0b7755a95c6a0315121671503c0ce09
Registration Details
Taiwan FDA Registration: d0b7755a95c6a0315121671503c0ce09
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Leica" Surgipath Cell-freezing apparatus and reagents for in vitro diagnostic use (Non-Sterile)
TW: "ๅพ ๅก"็‘ŸๅŸบๅธ•ๆ€้ซ”ๅค–่จบๆ–ท็”จ็š„็ดฐ่ƒžๅ†ทๅ‡่จญๅ‚™ๅŠๅๆ‡‰ๅŠ‘ (ๆœชๆป…่Œ)
Risk Class 1
MD

Registration Details

d0b7755a95c6a0315121671503c0ce09

Ministry of Health Medical Device Import No. 013257

DHA09401325705

Company Information

United States

Product Details

Limited to the first level identification range of cell cryogenic equipment and reactants (B.9225) for in vitro diagnosis of medical device management methods.

B Hematology and pathology devices

B9225 Cell cryogenic equipment and reactants for in vitro diagnostics

Imported from abroad

Dates and Status

Aug 02, 2013

Aug 02, 2023